Skip to main content
Clinical Trials/NCT06120478
NCT06120478CompletedNot Applicable

The Second Affiliated Hospital of Air Force Military Medical University

Tang-Du Hospital1 site in 1 country1,300 target enrollmentStarted: January 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,300
Locations
1
Primary Endpoint
death

Study Overview

Brief Summary

Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
  • Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
  • Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
  • Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
  • Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
  • Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk events after head and neck revascularization are 50% to 69%;
  • Sign the project informed consent form

Exclusion Criteria

  • Patients with poor overall condition and intolerance to general anesthesia;
  • Patients with mental illness or severe mental illness;
  • Severe respiratory system diseases;
  • Pregnant and lactating women;
  • Participating in another clinical study;
  • Patients with advanced tumors or those who are expected to die within one year;

Outcomes

Primary Outcomes

death

Time Frame: one year

Secondary Outcomes

  • Recurrence of stroke(one year)

Investigators

Sponsor
Tang-Du Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials